According to recent research, magnesium orotate, a combination of magnesium and orotic acid, can be used as an adjuvant treatment for type 2 diabetes, hypertension, congestive heart failure, and post-operative cardiac conditions
WO2019239340A1 - Reduced glutathione in a highly soluble, amorphous solid form, and process for the preparation thereof - Google Patents Reduced glutathione in a highly soluble, amorphous solid form, and process for the preparation thereof Download PDF Info Publication number WO2019239340A1 WO2019239340A1 PCT/IB2019/054906 IB2019054906W WO2019239340A1 WO 2019239340 A1 WO2019239340 A1 WO 2019239340A1 IB 2019054906 W IB2019054906 W IB 2019054906W WO 2019239340 A1 WO2019239340 A1 WO 2019239340A1 Authority WO WIPO (PCT) Prior art keywords glutathione reduced glutathione sodium salt product aqueous solution Prior art date Legal status (The legal status is an assumption and is not a legal conclusion
This formula is designed for individuals focused on longevity, recovery, environmental stress protection, and overall cellular health
A dopamine agonist is a drug containing a molecule that binds to and activates dopamine receptors, similar to dopamine itself, thus compensating for low dopamine levels
The results are not particularly promising, as a possible dissociation of curcumin from lanthanide(III) ions could limit the use of these compounds in the treatment of osteoporosis ( The mixed ligand-based complexes ( Zr IV -02 , Rh III -03 , Th IV -01 , UO 2 IV -01 , and UO 2 IV -02 ), including curcumin and ( E )-1-(3,4-dimethylphenyl)-2-(4-hydroxy-3-methoxycyclohex-3-en-1-ylidene)ethan-1-one exhibited different geometries and were biologically active
Therefore, ARK5 inhibitors such as WZ4003 and HTH-01-015 can be used to reduce Nrf2 levels in the nucleus and drive ferroptosis [121, 122]